Cogent Biosciences, Inc.

COGT ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
144 Dec 29, 2025
144 Dec 29, 2025
144 Dec 29, 2025
4 Dec 19, 2025 4
4 Dec 19, 2025 4
4 Dec 19, 2025 4
4 Dec 19, 2025 4
4 Dec 19, 2025 4
4 Dec 19, 2025 4
8-K Dec 8, 2025 8-K
8-K Nov 18, 2025 8-K
SCHEDULE 13D/A Nov 17, 2025
SCHEDULE 13G/A Nov 14, 2025
SCHEDULE 13G/A Nov 14, 2025
SCHEDULE 13G/A Nov 14, 2025
SCHEDULE 13G/A Nov 14, 2025
SCHEDULE 13G/A Nov 14, 2025
8-K Nov 13, 2025 8-K
424B5 Nov 12, 2025 424B5
424B5 Nov 12, 2025 424B5
FWP Nov 12, 2025 FWP
424B5 Nov 12, 2025 424B5
424B5 Nov 12, 2025 424B5
8-K Nov 10, 2025 8-K
S-3ASR Nov 7, 2025 S-3ASR
← Newer Page 3 of 25 · 616 filings Older →